What is the safest treatment for a 21-week pregnant female with a urinary tract infection (UTI) caused by Enterococcus faecalis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Enterococcus faecalis UTI in a 21-Week Pregnant Female

For a 21-week pregnant female with a urinary tract infection caused by Enterococcus faecalis, ampicillin is the safest and most effective first-line treatment option. 1, 2

First-Line Treatment Options

  • Ampicillin is the drug of choice for enterococcal infections, including UTIs during pregnancy, due to its established safety profile and efficacy against E. faecalis 1
  • Ampicillin achieves high urinary concentrations that can effectively treat E. faecalis UTIs, even in cases where the organism shows intermediate susceptibility in laboratory testing 1
  • For patients with normal renal function, a typical dosage of ampicillin is 500 mg PO/IV every 8 hours 1
  • Clinical and microbiological eradication rates with ampicillin for E. faecalis UTIs have been reported at 88.1% and 86%, respectively 1

Alternative Options (if ampicillin allergy or resistance)

  • Nitrofurantoin is FDA-approved for UTIs caused by E. faecalis and is considered safe during the second trimester of pregnancy 1, 3

    • Nitrofurantoin has good in vitro activity against E. faecalis and is recommended by WHO as a first-choice option for lower UTIs 1, 4
    • Avoid nitrofurantoin near term (>36 weeks) due to risk of hemolytic anemia in the newborn 5
  • Fosfomycin is FDA-approved for UTIs caused by E. faecalis and has a favorable safety profile during pregnancy 1

    • Single-dose treatment makes it convenient for patient adherence 4
    • Limited data from observational studies show promising results for uncomplicated UTIs due to E. faecalis 1

Special Considerations During Pregnancy

  • Untreated UTIs during pregnancy can lead to significant maternal and perinatal morbidity and mortality, including progression to pyelonephritis and preterm labor 3, 5
  • E. faecalis is the second most common Gram-positive pathogen causing UTIs in pregnancy after Group B Streptococcus 3
  • Susceptibility testing is crucial for guiding therapy, as resistance patterns can vary 3
  • For E. faecalis specifically, susceptibility to ampicillin remains high (>90% in recent studies) 3

Treatment Algorithm

  1. First-line: Ampicillin 500 mg PO every 8 hours for 7 days 1
  2. If penicillin allergy: Nitrofurantoin 100 mg PO every 12 hours for 7 days (if <36 weeks gestation) 1, 4
  3. Alternative: Fosfomycin 3g single oral dose 1, 4
  4. For severe infection/pyelonephritis: Hospitalization with IV ampicillin, possibly combined with gentamicin for synergistic effect (short course only due to nephrotoxicity risk) 1, 5

Important Caveats

  • Avoid fluoroquinolones during pregnancy due to potential fetal cartilage damage 5
  • Aminoglycosides (gentamicin) should be used cautiously and only for severe infections due to nephrotoxicity and ototoxicity risks 1
  • For vancomycin-resistant E. faecalis (rare), consultation with infectious disease specialists is essential 6
  • Follow-up urine culture after treatment completion is recommended to confirm cure 3

Monitoring and Prevention

  • Monitor for treatment response within 48-72 hours 5
  • Ensure adequate hydration during treatment 1
  • Consider prophylaxis for recurrent UTIs with daily low-dose nitrofurantoin (if <36 weeks) or cephalexin 1
  • Encourage urge-initiated voiding and post-void residual assessment 1

By following this treatment approach, the risk of complications from E. faecalis UTI during pregnancy can be minimized while ensuring maternal and fetal safety.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Enterococcus Faecalis Biofilm Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Antimicrobial susceptibility patterns of uropathogens isolated from pregnant women in KwaZulu-Natal Province: 2011 - 2016.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 2020

Research

Treatment of resistant enterococcal urinary tract infections.

Current infectious disease reports, 2010

Research

Urinary tract infections in pregnancy.

Current opinion in urology, 2001

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.